Prospective longitudinal evaluation of doxorubicin-induced cardiomyopathy in sarcoma patients: A report of the Late Effects Surveillance System (LESS)

M. Paulides, A. Kremers, W. Stöhr, S. Bielack, H. Jürgens, J. Treuner, J. D. Beck, T. Langer^*

^*Korrespondierende/r Autor/-in für diese Arbeit